Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2003 1
2004 2
2005 2
2006 5
2007 2
2008 2
2009 3
2010 6
2011 7
2012 6
2013 7
2014 9
2015 16
2016 16
2017 10
2018 9
2019 5
2020 6
2021 6
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 27015550

101 results

Results by year

Filters applied: . Clear all
Page 1
A randomized phase III study evaluating the efficacy of single-dose NEPA, a fixed antiemetic combination of netupitant and palonosetron, versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC).
Zhang L, Lu S, Feng J, Dechaphunkul A, Chang J, Wang D, Chessari S, Lanzarotti C, Jordan K, Aapro M. Zhang L, et al. Ann Oncol. 2018 Feb 1;29(2):452-458. doi: 10.1093/annonc/mdx698. Ann Oncol. 2018. PMID: 29092012 Free PMC article. Clinical Trial.
Evaluation of the efficacy of palonosetron for prevention of chemotherapy-induced nausea and vomiting in patients with gastric cancer treated with S-1 plus cisplatin.
Oyama K, Fushida S, Kaji M, Takeda T, Yabushita K, Nezuka H, Kinami S, Kadoya N, Takai Y, Tsukioka Y, Ohyama S, Tsuji K, Tsukada T, Kinoshita J, Fujimura T, Ohta T. Oyama K, et al. Int J Clin Oncol. 2016 Jun;21(3):483-90. doi: 10.1007/s10147-015-0916-2. Epub 2015 Oct 27. Int J Clin Oncol. 2016. PMID: 26507140 Free PMC article.
Efficacy and safety of triple therapy with aprepitant, palonosetron, and dexamethasone for preventing nausea and vomiting induced by cisplatin-based chemotherapy for gynecological cancer: KCOG-G1003 phase II trial.
Takeshima N, Matoda M, Abe M, Hirashima Y, Kai K, Nasu K, Takano M, Furuya K, Sato S, Itamochi H, Tsubamoto H, Hasegawa K, Terao K, Otsuki T, Kuritani K, Ito K. Takeshima N, et al. Support Care Cancer. 2014 Nov;22(11):2891-8. doi: 10.1007/s00520-014-2280-6. Epub 2014 May 14. Support Care Cancer. 2014. PMID: 24825735 Clinical Trial.
Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial.
Saito M, Aogi K, Sekine I, Yoshizawa H, Yanagita Y, Sakai H, Inoue K, Kitagawa C, Ogura T, Mitsuhashi S. Saito M, et al. Lancet Oncol. 2009 Feb;10(2):115-24. doi: 10.1016/S1470-2045(08)70313-9. Epub 2009 Jan 8. Lancet Oncol. 2009. PMID: 19135415 Clinical Trial.
Aprepitant plus granisetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients with gastric cancer treated with S-1 plus cisplatin.
Oyama K, Fushida S, Kaji M, Takeda T, Kinami S, Hirono Y, Yoshimoto K, Yabushita K, Hirosawa H, Takai Y, Nakano T, Kimura H, Yasui T, Tsuneda A, Tsukada T, Kinoshita J, Fujimura T, Ohta T. Oyama K, et al. J Gastroenterol. 2013 Nov;48(11):1234-41. doi: 10.1007/s00535-012-0746-1. Epub 2013 Jan 22. J Gastroenterol. 2013. PMID: 23338487
101 results